Compare VSAT & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSAT | CRL |
|---|---|---|
| Founded | 1986 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.8B |
| IPO Year | 1996 | 1999 |
| Metric | VSAT | CRL |
|---|---|---|
| Price | $71.68 | $296.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $59.80 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 2.0M | 923.3K |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $5.32 | N/A |
| Revenue Next Year | $3.57 | $3.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $26.10 | $144.26 |
| 52 Week High | $93.03 | $300.59 |
| Indicator | VSAT | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 44.07 | 76.44 |
| Support Level | $67.49 | $149.72 |
| Resistance Level | $75.57 | N/A |
| Average True Range (ATR) | 3.62 | 9.71 |
| MACD | -1.38 | 0.64 |
| Stochastic Oscillator | 11.59 | 93.34 |
Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.